Literature DB >> 34628502

A Review of Adverse Events From the Use of Diphtheria Antitoxin (DAT) in the United States, 2004-2019.

Valerie D Bampoe1, Haley C Boswell2, Yon C Yu2, Anna M Acosta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34628502      PMCID： PMC9276519          DOI： 10.1093/cid/ciab899

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


× No keyword cloud information.
  3 in total

1.  Availability of diphtheria antitoxin through an investigational new drug protocol.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-05-02       Impact factor: 17.586

2.  Respiratory Illness Caused by Corynebacterium diphtheriae and C. ulcerans, and Use of Diphtheria Antitoxin in the United States, 1996-2018.

Authors:  John O Otshudiema; Anna M Acosta; Pamela K Cassiday; Stephen C Hadler; Susan Hariri; Tejpratap S P Tiwari
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

3.  Diphtheria Antitoxin Administration, Outcomes, and Safety: Response to a Diphtheria Outbreak in Cox's Bazar, Bangladesh.

Authors:  Nell Eisenberg; Isabella Panunzi; Anja Wolz; Chiara Burzio; Anna Cilliers; Md Ariful Islam; Waqar Mohammad Noor; Oren Jalon; Deanna Jannat-Khah; Julita Gil Cuesta
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.